<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16570">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01823809</url>
  </required_header>
  <id_info>
    <org_study_id>METc2011.084</org_study_id>
    <nct_id>NCT01823809</nct_id>
  </id_info>
  <brief_title>Non-invasive and Invasive Assessment of Coronary Artery Disease</brief_title>
  <acronym>COMFORT</acronym>
  <official_title>Assessment of Coronary Artery Disease With Multi-Slice Computed Tomography Combined With Stress Cardiac Magnetic Resonance Imaging Compared to Coronary Angiography Combined With Fractional Flow Reserve Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Centre Groningen</source>
  <oversight_info>
    <authority>Netherlands: Medical Ethics Review Committee (METC)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the diagnostic accuracy of a combined use of
      non-invasive coronary angiography with multi-slice computed tomography (MSCT) and stress
      cardiac magnetic resonance (CMR) imaging in patients with obstructive lesions on MSCT and
      with low to intermediate pre-test likelihood of coronary artery disease (CAD) as compared to
      invasive coronary angiography (CAG) and Fractional Flow Reserve (FFR) measurements.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Diagnostic accuracy to detect ischemia with stress CMR compared to FFR</measure>
    <time_frame>one month</time_frame>
    <safety_issue>No</safety_issue>
    <description>The diagnostic accuracy of MSCT coronary angiography in combination with stress CMR imaging as compared to invasive CAG and FFR measurement, as a standard of reference to detect obstructive and hemodynamically significant stenoses in patients with low to intermediate pre-test likelihood of CAD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predictive value for treatment strategy of a non-invasive strategy with MSCT and stress CMR compared to an invasive strategy</measure>
    <time_frame>one month</time_frame>
    <safety_issue>No</safety_issue>
    <description>to evaluate whether MSCT coronary angiography in combination with stress CMR imaging may accurately predict treatment strategy (medical therapy versus revascularization therapy) as compared to CAG and FFR in patients with low to intermediate pre-test likelihood of CAD.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>adenosine stress Cardiac Magnetic Resonance Imaging</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with stable angina pectoris with low to intermediate pre-test likelihood of
             CAD;

          2. no previous history of CAD;

          3. obstructive stenosis (â‰¥50% luminal narrowing) on MSCT coronary angiography;
             4.informed consent.

        Exclusion Criteria:

          1. patients with a previous history of CAD;

          2. patients with contraindications for MSCT: a.cardiac rhythms other than sinus rhythm,
             b.pregnancy, c.allergy for contrast medium, d.renal failure (estimated glomerular
             filtration rate (eGFR) &lt; 50ml/min), e.resting heart rate &gt;75 bpm plus
             contra-indications for beta-blockade, f. weight &gt;100 kilograms;

          3. contraindications for cardiac magnetic resonance (CMR) imaging: a.MR-incompatible
             implants, b. Claustrophobia, c. contraindications for adenosine: i. known or
             suspected hypersensitivity to adenosine, ii. known or suspected bronchoconstrictive
             or bronchospastic disease, iii. 2nd or 3rd degree atrioventricular (AV) block, iv.
             Sinus bradycardia (heart rate &lt; 45 bpm), v. Systemic arterial hypotension (&lt;90 mmHg).
             d. contraindications for gadolinium: i. renal failure (estimated eGFR &lt;30 ml/min);

          4. no informed consent.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabija Pundziute, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen, Department of Cardiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wouter G Wieringa, MD</last_name>
    <phone>+31 50 3613485</phone>
    <email>w.g.wieringa@umcg.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabija Pundziute, MD, PhD</last_name>
    <phone>+31 50 3614977</phone>
    <email>g.pundziute@umcg.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medical Center Groningen, Departments of Cardiology and Radiology</name>
      <address>
        <city>Groningen</city>
        <zip>9700 RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gabija Pundziute, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tineke Willems, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wouter G Wieringa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chris Lexis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 29, 2013</lastchanged_date>
  <firstreceived_date>March 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Groningen</investigator_affiliation>
    <investigator_full_name>Gabija Pundziute</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Computed Tomography</keyword>
  <keyword>Cardiac Magnetic Resonance</keyword>
  <keyword>Fractional Flow Reserve</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adenosine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
